Critically, we show that their gene expression, alike BRCA1, influences the prognosis of BC patients, in lines with previous reports identifying splicing dysregulation as a driving force of BC pathobiology (reviewed in [58]). This evidence concerns the gene BRCA1 and breast cancer.